Page last updated: 2024-11-03

ag 1879 and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ag 1879 has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 3 studies

3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine: Fyn kinase inhibitor

Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Williams, NK1
Lucet, IS1
Klinken, SP1
Ingley, E1
Rossjohn, J1
Gamas, P1
Marchetti, S1
Puissant, A1
Grosso, S1
Jacquel, A1
Colosetti, P1
Pasquet, JM1
Mahon, FX1
Cassuto, JP1
Auberger, P1
Wilson, MB1
Schreiner, SJ1
Choi, HJ1
Kamens, J1
Smithgall, TE1

Other Studies

3 other studies available for ag 1879 and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
Crystal structures of the Lyn protein tyrosine kinase domain in its Apo- and inhibitor-bound state.
    The Journal of biological chemistry, 2009, Jan-02, Volume: 284, Issue:1

    Topics: Adenylyl Imidodiphosphate; Animals; Apoenzymes; B-Lymphocytes; Catalytic Domain; Crystallography, X-

2009
Inhibition of imatinib-mediated apoptosis by the caspase-cleaved form of the tyrosine kinase Lyn in chronic myelogenous leukemia cells.
    Leukemia, 2009, Volume: 23, Issue:8

    Topics: Antineoplastic Agents; Apoptosis; Benzamides; Caspase 3; Caspase 9; Caspase Inhibitors; Enzyme Activ

2009
Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
    Oncogene, 2002, Nov-21, Volume: 21, Issue:53

    Topics: Apoptosis; Cell Division; Cell Transformation, Neoplastic; DNA-Binding Proteins; Dose-Response Relat

2002